Please login to the form below

Not currently logged in
Email:
Password:

DiCE Molecules

This page shows the latest DiCE Molecules news and features for those working in and with pharma, biotech and healthcare.

Sanofi bets on DiCE to find oral alternatives to injectable drugs

Sanofi bets on DiCE to find oral alternatives to injectable drugs

Sanofi has made a small-molecule discovery engine developed by US biotech DiCE Molecules a core part of its R&D portfolio. ... DiCE's approach to drug discovery focuses on targeting protein-protein interactions that to date have only been addressed with

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Deal Watch March 2016 Deal Watch March 2016

    Acquisition – division. $5, 869. DiCE Molecules/ Sanofi. Technology platform to select and optimise drug-like ligands targeting a range of therapeutic areas. ... Acquisition of royalty rights. $1, 140. Blueprint Medicines/ Roche. Small molecules

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

The new UK government-pharma industry pricing agreement – welcome news, but there are lessons to be learnt
...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again – in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics